ANTICORPI ANTI VIRUS DELL'EPATITE C (HCV) IN PAZIENTI AFFETTI DA INSUFFICIENZA RENALE CRONICA (IRC) IN TERAPIA CONSERVATIVA: PREVALENZA E FATTORI DI RISCHIO

Translated title of the contribution: Hepatitis C virus (HCV) infection in chronic renal failure (CRF) patients on conservative therapy: Prevalence and risk factors

F. Fabrizi, D. Marcelli, G. Bacchini, I. Guarnori, G. Erba, F. Locatelli

Research output: Contribution to journalArticlepeer-review

Abstract

There are no data regarding HCV prevalence in CRF patients not requiring dialysis. In order to assess prevalence and risk factors for HCV infection in CRF patients on conservative therapy we tested by second-generation assays 221 predialysis CRF patients attending our Department. Forty-four patients (20%) were anti-HCV positive. Anti-HCV positivity was related to blood transfusion requirement, past or current elevations of transaminase levels and, to a lesser degree, CRF duration. The prevalence of anti-HCV positivity among CRF patients who were never transfused was about 10 times higher than among blood donors. Our data show that predialysis CRF patients should be considered a specific risk group for HCV infection; blood transfusion history and duration of CRF are risk factors for acquisition of HCV infection; HCV may play a role in the development of liver disease in this clinical setting.

Translated title of the contributionHepatitis C virus (HCV) infection in chronic renal failure (CRF) patients on conservative therapy: Prevalence and risk factors
Original languageItalian
Pages (from-to)103-109
Number of pages7
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume11
Issue number2
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'Hepatitis C virus (HCV) infection in chronic renal failure (CRF) patients on conservative therapy: Prevalence and risk factors'. Together they form a unique fingerprint.

Cite this